Tag Archives | breast cancer market research

The Art of the KOL Interview

Pharma and biotech companies routinely seek the opinion of leading academics and researchers, but interviewing thought leaders (more commonly known as Key Opinion Leaders or KOLs) is an art, rather than a science.

Continue Reading

Understanding the Pharma Biotech Competitive Landscape

One of the pharma marketing strategy consulting services that we offer clients is a competitive landscape, market opportunity report. These custom reports analyze a pathway, disease, tumor type or competitive set, and can include a thorough analysis of clinical data, biomarkers, epidemiology, market size and competitor activity. All our work comes with actionable insights and […]

Continue Reading

The relationship between HRT and Breast Cancer

Sally Church on Pharma Strategy Blog discusses the issue of to what extent hormone replacement therapy (HRT) is linked to a higher incidence of breast cancer? Recent data published in the Journal of the American Medical Association (JAMA) showed a reduction in breast cancer incidence for those taking conjugate equine estrogens.¬† This is in sharp […]

Continue Reading

Nanoparticles offer promise for improved drug delivery in breast cancer

Nanotechnology is expected to provide major breakthroughs in how drugs cross the blood-brain barrier and reach into tumors. ¬†That promise is already starting to be seen. Research by Julia Ljubimova and her team at Cedars-Sinai Medical Center was recently published in the AACR journal, Cancer Research. They showed that biodegradable nanoparticles containing trastuzumab (herceptin), dramatically […]

Continue Reading